Vicki Gee Norton

Practice Details

• Firm Information
  Position

  Partner

  Firm Name

  Duane Morris LLP
• Representative Cases & Transactions
  Cases

  Representative Matters: Represented Allele Biotech in company side IP diligence in connection with its licensing agreement to exp
  Astellas' access to Allele's induced pluripotent stem cell (iPSC) technologies for various cell therapy programs.
  Secured for Allele Biotechnology key patents for its technology for re-programming stem cells without the danger of foreign or viral integrated DNA in methods which are especially adaptable for use in regenerative medicine technologies, which meet regulatory GMP requirements. The technology has been licensed to biopharmaceutical companies.
  Obtained patent for California Safe Soil, for its a nutrient rich fertilizer made from fresh food waste. California Safe Soil received a 2017 California Governor's Environmental
  Economic Leadership award for its innovative technology that recycles organic food waste into fertilizer
  feed for agricultural uses.
  H
  led global patent strategy for leading Taiwanese biopharmaceutical company focused on antibody glyco-engineering,
  obtained key patent for foundational glyco-engineering technology.
  H
  led global patent strategy for Nanobot Biosciences, a pioneer in the field of nucleic acid origami therapeutics.
  H
  led company-side IP diligence for OcuNexus' License & Collaboration Agreement with Eyevance Pharmaceuticals, in which Ocunexus out-licensed one of its drug c
  idates.
  Represented Quest Diagnostics in the sale of a stream of royalty revenue from commercialization of the drug c
  idate Ibrutinib to Royalty Pharma for $485 million in cash.
  Teva v. Watson, Case No. 10-CV-5078 (D.N.J. - C.Cecchi). Represented Watson Pharmaceuticals, Inc. in Hatch-Waxman Litigation against Teva Pharmaceutical Industries Ltd. concerning the Parkinson's disease drug AZILECT, the active ingredient of which is rasagiline. The matter was settled during trial.
  Advised Quest Diagnostics on intellectual property matters in connection with Quest's definitive merger agreement with Celera Corporation.
  Counsel to a leading biopharmaceutical company in its defense against a dem
  for multi-million dollar damages in a patent infringement suit concerning a biologic drug useful in the treatment of rheumatoid arthritis
  dismissal of the case on a motion following the close of discovery was affirmed on appeal.
  Counsel to a leading biopharmaceutical company
  affiliates in actions brought for declaratory judgment that no royalties were owed for production of biopharmaceuticals, where a multi-billion dollar claim for royalties was at stake
  cases brought by several biopharmaceutical companies against same patentee were consolidated in a multi-district proceeding
  following discovery of invalidity
  prior art witnesses the patentee filed a covenant not to sue
  the case settled in a manner the client found favorable.
  Represented a trustee for a biotechnology liquidating trust in defense to claim of breach of license agreement
  obtained dismissal of claims brought against the trust.
  Represented a manufacturer of fluorescent calcium indicator probes in defending against patent infringement claims, obtaining a settlement the client found favorable.
  Represented a manufacturer of nanoparticle technology in an action seeking a declaratory judgment of ownership
  obtained settlement.
  Represented a producer of transgenic plant seeds in patent infringement actions, including cases consolidated for discovery with other cases brought by patentee in the same jurisdiction.
  Represented a leading manufacturer of life sciences products in a patent infringement suit involving energy transfer fluorescent indicators used in DNA sequencing
  obtained summary judgment of infringement
  after completion of discovery, the case settled in a manner the client found favorable.
  Represented a patentee in actions seeking damages for infringement of an injection molding patent.
  H
  led client's trade secret
  licensing diligence in connection with its acquisitions of a fertility diagnostic specialist
  a diagnostic pathology service.